JSP
MEDP icon

Jackson Square Partners’s Medpace MEDP Stock Holding History

Jackson Square Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,843
Closed -$9.17M – 28
2025
Q3 		$9.17M Buy
17,843
+8,517
+91% +$3.72M 3.71% 8
2025
Q2 		$2.93M Sell
9,326
-57,233
-86% -$17.2M 1.08% 42
2025
Q1 		$20.3M Buy
66,559
+5,514
+9% +$1.85M 2.73% 14
2024
Q4 		$20.3M Sell
61,045
-12,215
-17% -$4.14M 2.11% 23
2024
Q3 		$24.5M Buy
73,260
+16,498
+29% +$6.27M 2.11% 22
2024
Q2 		$23.4M Sell
56,762
-23,155
-29% -$9.17M 1.43% 32
2024
Q1 		$32.3M Buy
+79,917
New +$28.1M 1.34% 33

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jackson Square Partners's MEDP Position: Q4 2025 in Review

Jackson Square Partners sold out of Medpace (MEDP) in Q4 2025, closing a stake of 17,843 shares — an estimated $9.17M sold.

Jackson Square Partners first reported a position in MEDP in Q1 2024 and held it in 7 quarters. The position peaked at $32.3M in Q1 2024. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Jackson Square Partners reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Jackson Square Partners sold 17,843 Medpace shares in Q4 2025, an estimated $9.17M.
  • Jackson Square Partners first reported a position in Medpace in Q1 2024 and held it in 7 quarters.
  • Jackson Square Partners's Medpace position peaked at $32.3M in Q1 2024.
  • 785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Jackson Square Partners's 13F filing for Q4 2025.